+794.9%
MRNA vs GD
+5.9%
+789.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GD | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +0.1% | -3.6% | -3.5% |
| 7D | -12.1% | +2.7% | -14.8% | -12.9% |
| 30D | -1.3% | +8.6% | -9.9% | -4.9% |
| 3M | +250.9% | -7.1% | +258.0% | +266.2% |
| 6M | +343.0% | +7.5% | +335.6% | +317.7% |
| YTD | +657.4% | +9.9% | +647.5% | +589.4% |
| 1Y | +794.9% | +7.6% | +787.4% | +746.7% |
| All | +794.9% | +5.9% | +789.1% | +746.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GD.
Daily Out/Under-Performance
Portfolio return minus GD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling